Side Effects Increased in Combo Treatment for Breast Cancer

Advanced breast cancer patients who are treated with a combination of drugs that target specific cancer molecules are at increased risk of suffering side effects.

Researchers examined data from 16 randomized clinical trials that included more than 8,500 patients with advanced hormone receptor-positive breast cancer. The team analyzed hormonal therapies given in combination with targeted drugs such as CDK4/6 inhibitors, mTOR inhibitors and anti-HER2 agents.

The results, presented at the Advanced Breast Cancer Fourth International Consensus Conference, revealed that combining targeted drugs with hormone therapy significantly increased the risk of severe or life-threatening adverse events such as fatigue, rash, nausea, diarrhea and liver enzyme elevation.

CDK4/6 inhibitors were associated with low white blood cell counts; mTOR inhibitors were associated with sore and inflamed mouth; PI3K inhibitors were linked to hyperglycemia (high blood sugar levels); and anti-HER2 agents caused diarrhea.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement